Description:
Global Carbetocin Injection Market: Introduction
Carbetocin is a drug that is used to control postpartum hemorrhage?bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin, which causes contraction of the uterus. According to CIC Edizioni Internazionali, almost 500.000 women die due to this potentially preventable cause each year, and an estimated quarter of these deaths occur as a consequence of hemorrhage at the time of delivery. Carbetocin is a long-acting synthetic oxytocin analogue, 1-deamino-1-monocarbo-(2-O-Methyltyrosine)-oxytocin, firstly described in 1987. A single dose of carbetocin has been hypothysed to act as a 16 hours intravenous oxytocin infusion regarding the increase in uterine tone and the reduction of the risk of PPH in elective caesarean section.
Report Request Overview:
https://www.transparencymarketresearch.com/carbetocin-injection-mar...
Key Drivers of Global Carbetocin Injection Market:
Prevalence of postpartum hemorrhage
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality. Maternal deaths and the maternal mortality ratio (MMR) have reduced globally from 543 000 and 400 per 100 000 live births to 287 000 and 210 per 100 000 live births, respectively. The WHO and professional bodies recommend active management of the third stage of labor (AMTSL) for all vaginal births in order to prevent PPH. An oxytocin injection is the recommended first line uterotonic medicine for prevention and treatment of PPH, as it is more effective than ergometrine and other uterotonics and has relatively fewer side-effects. Incidence of PPH is reported to be around 2% to 4% after vaginal delivery, and 6% after cesarean section; with uterine atony being the cause in about 50% cases. Every year, about 14 million women around the world suffer from PPH.
Request Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Increase in birth rate
Pregnancy and birth rates among teenagers in the U.S are significantly high among all developed countries. Declining birth rates and an increased life expectancy have resulted in a worldwide shift in the population age distribution. Changes in the birth rate can come about not only because of changes in age-specific fertility rates but also because of structural changes in the population. According to Theoretical Population Biology, even though birth rates are dropping all over the world, thanks to increases in food security, affluence, and urbanization, the world's population is estimated to exceed 8 billion (up from today's 6.5 billion) by 2030, and might reach 9 billion by 2050.
North America to Account for Major Share of Global Carbetocin Injection Market
• North America is projected to account for a major share of the global carbetocin injection market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and introduction of technologically advanced products in the market. Europe is expected to be the second-largest market during the forecast period owing to advanced facilities provided by the hospital infrastructure in the region.
• The carbetocin injection market in Asia Pacific is likely to expand at a high CAGR during the forecast period owing to rising awareness and acceptance & adoption of new techniques in the region
Key Players Operating in Global Carbetocin Injection Market:
The global carbetocin injection market is highly consolidated owing to the presence of several key players. Leading players operating in the global carbetocin injection market include:
• Ferring Pharmaceuticals
• Boya Bio
• Hybio Pharmaceutical
• Beacon Pharmaceuticals Ltd.
• Chengdu Shengnuo Biotechnology
• Pfizer
• Tibet Aim Pharm Inc (Aim Pharm)
:
Global Carbetocin Injection Market, by Type
• Original Drug
• Generic Drug
Global Carbetocin Injection Market, by End-user
• Hospitals
• Clinics
• Other

Pre Book:
https://www.transparencymarketresearch.com/checkout.php?rep_id=8060...
More Trending Reports by Transparency Market Research:
Elderly and Disabled Assistive Devices Market:
https://www.prnewswire.com/news-releases/elderly-and-disabled-assis...
Anti-aging Market:
https://www.prnewswire.com/news-releases/anti-aging-market-to-surpa...

About Us:
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact us:
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/